Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-2254

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-2254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Oxcarbazepine is a medication that comes in a quantity of 30 HD2 and requires a prescription. The NDC number is 70518-2254-00, and it was manufactured by Breckenridge in Boca Raton, FL 33487. The directions for use can be found in the package insert. The medication should be stored at 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F) [See USP]. The medication was repackaged by RemedyRepack Inc. in Indiana, PA 15701.*
FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

Figure 1 (Oxcarbazepine 02)
This is a graph showing the exit rate over time for a study with a placebo group. The log-rank test resulted in a p-value of 0.0001. The x-axis shows the time on trial from day 2 to day 11, while the y-axis shows the exit rate ranging from 0 to 0.9.*
FDA Label Image

Figure 2 (Oxcarbazepine 03)

FDA Label Image

Figure 3 (Oxcarbazepine 04)

Figure 3 (Oxcarbazepine 04)
This is a statistical analysis report of a treatment study. It shows the p-value obtained from a log-rank test. There is a chart showing the time to exit (days) for a treatment group classified under HIGH and LOW. The text seems to lack context to fully understand the study.*
FDA Label Image

Figure 4 (Oxcarbazepine 05)

Figure 4 (Oxcarbazepine 05)
This appears to be a survival analysis output table showing the Exitrate, log-rank test p-value, and time to exit (in days) for a Treatment Group with a HIGH value compared to a LOW value. It is not clear what the specific analysis is addressing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.